Special Notice NAICS 541714

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

🏢 ENERGY, DEPARTMENT OF 📅 Posted 2026-09-22 ⏳ Due 2027-03-22T23:00:00+00:00
A platform that predicts the right signal peptide for a specific protein Many medicines, vaccines, and biotechnology products rely on proteins reaching the right cellular compartment or secretion outside a cell. Whether a protein gets there in enough quantities depends on its signal peptide or leader sequence. Scientists can identify many existing signal peptides, but predicting which one will work best for a specific protein remains difficult. SignalGen uses generative AI to predict the signal peptide most likely to guide a protein to the right location. To make that prediction, it considers the protein, where it needs to go, and the organism it comes from. This approach gives researchers a new way to improve protein expression for medicines, vaccines, and biotechnology products. Overview: Proteins carry out many of the body's essential functions, but they can only do their job if they reach the right place inside or outside a cell. Many proteins rely on signal peptides to get there. Typically, a signal peptide is a short sequence segment at the beginning of a protein that acts like a built-in address label, helping direct the protein to the location where it is needed. Pred...

Notice ID: 8cdf1c48ac25413ebdb2ec1fbecfd1de · View on SAM.gov ↗

Explore more federal-contracting data

Browse opportunities by NAICS code · set-aside category · state & jurisdiction · buying agency

Win more federal contracts

BidChamp gives small businesses AI-powered bid writing, document analysis, and recompete forecasting - for free during your trial.

Sign up free - 14-day trial, no card required